HUMAN BIOBANKING APPLICATIONS GLOBAL TRENDS, ESTIMATES AND

FORECASTS, 2014-2020

PRICE: US$4800
NO. OF PAGES: 596

TABLES/CHARTS: 157
REPORT CODE: ARMMR163N

PUBLICATION: MAY 2016

www.axisresearchmind.com | Copyright 2016 | All Rights Reserved

www.axisresearchmind.com | Copyright 2016 | All Rights Reserved

HUMAN BIOBANKING APPLICATIONS - GLOBAL TRENDS, ESTIMATES

AND FORECASTS, 2014-2020

SEGMENTATION
Human Biobanking Applications
The analysis primarily deals with human biobanking applications market. Further, the
subdivided categories include:

STEM CELLS

BLOOD1 & BLOOD PRODUCTS

ORGANS2

ADVANCED APPLICATIONS
o

BIOMARKERS

GENOMICS3

DRUG DISCOVERY

FORENSICS

RESEARCH

PHARMACEUTICALS

OTHER4

1.
2.
3.
4.

Red Blood Cells, Plasma and Platelets

Tissue Sections, Liver, Eyes, Kidney, Brain, Heart and Other
DNA, RNA, Protein Extraction, Molecular Derivatives, Cell Cultures, Microarrays, Cytogenetics, etc.
Body Fluids (Synovial, Urine, Sputum, Buccal Scrapings and Sperm), Contract Services and Process Chemicals

HUMAN BIOBANKING APPLICATIONS

- GLOBAL MARKET WATCH, 2014-2020
Human Biobanking market is expected to reach US$37.1 billion 2020 primarily supported
by application; Stem Cells, Blood and Blood Products, Research and
Pharmaceuticalsetc. Among the Human Biobanking Application market, Advance
Application is the fastest growing market with a CAGR of 9.65%. Organs and Research
application in human banking together accounts approximately for 24% of the market
share. Stem Cells, Blood and Blood Products, Research market with a positive growth
rate during the period. Human Biobanking Industry is playing an increasing role in
development of therapies and diagnosis of diseases with well-maintained researchers
and institutions.
Getting the most from our custom research
Knowing Future by Analyzing the Market in Key Growth Areas and New Technologies!!!

For more information on this report publication, please reach us at:

sales@axisresearchmind.com

www.axisresearchmind.com | Copyright 2016 | All Rights Reserved

HUMAN BIOBANKING APPLICATIONS - GLOBAL TRENDS, ESTIMATES

AND FORECASTS, 2014-2020

KEY COMPANIES PROFILED

VERICEL CORPORATION, ACORDA THERAPEUTICS, INC., ALPHA CORD, INC.,
AFFYMETRIX, INC., CELLERANT THERAPEUTICS, INC., CRYO-CELL INTERNATIONAL, INC.,
MESOBLAST, INC., BECKMAN COULTER, INC., BIOSTORAGE, LLC., CHART INDUSTRIES,
INC., CHARTER MEDICAL, LTD., CORD BLOOD REGISTRY, CRYOLIFE, INC.,
CRYOMAGNETICS, INC., CRYOPLUS, INC., CRYOXTRACT, HAMILTON STORAGE
TECHNOLOGIES, LABVANTAGE SOLUTIONS, INC., LABWARE, INC., LIFENET HEALTH,
QIAGEN NV, RAND CORPORATION, ABBOTT
LABORATORIES, STEM CELLS, INC., STEMCELL
Learn High Potential Market Dynamics
TECHNOLOGIES, INC., LIFELINE CELL
for Strategic Business Planning
TECHNOLOGY, THERMO FISHER SCIENTIFIC,
INC., WHEATON SCIENCE PRODUCTS, INC.,
PANASONIC BIOMEDICAL B.V, EPISTEM LTD., BBMRI, BIOBANK IRELAND TRUST, BIOKRYO
GMBH, BIOREP SRL P.IVA, BIOSTORAGE TECHNOLOGIES, INC., CRYO BIO SYSTEM, CRYOSAVE, AG, GE HEALTHCARE LIFE SCIENCES, SANOFI AVENTIS, SOVENTEC GMBH, TECAN,
UK STEM CELL BANK, CORDLIFE PTE., LTD., CRYOCORD SDN. BHD., CRYOLOGIC PTY.
LTD., GENESEARCH, OCIMUM BIOSOLUTIONS, RELIANCE LIFE SCIENCES, CHINA CORD
BLOOD CORPORATION, BABYCELL EGYPT, GAMIDA CELL LTD., & many more.

REPORT FOCUS
The report Human Biobanking Applications - Global Trends, Estimates and Forecasts,
2014-2020 reviews the latest human biobanking market trends with a perceptive
attempt to disclose the near-future growth prospects. An in-depth analysis on a
geographic basis provides strategic business intelligence for life science sector
investments. The study reveals profitable investment strategies for pharmaceutical
manufacturers, biotechnology companies, laboratories, Contract Research Organizations
(CROs) and many more in preferred locations.
The report focuses on the current market trends, estimates and forecasts for the
period 2014-2020. More than 1250 leading market players are identified and 107 key
companies that project improved market activities in the near future are profiled. The
report consists of 157 data charts describing the market shares, sales forecasts and
growth prospects. Moreover, key strategic activities in the market including
mergers/acquisitions, collaborations/partnerships, product launches/developments
are discussed.

For more information on this report publication, please reach us at:

sales@axisresearchmind.com

www.axisresearchmind.com | Copyright 2016 | All Rights Reserved

HUMAN BIOBANKING APPLICATIONS - GLOBAL TRENDS, ESTIMATES

AND FORECASTS, 2014-2020

GEOGRAPHIC COVERAGE
Estimates are based on online surveys using customized questionnaires by our research
team. Besides information from government databases, company websites, press
releases & published research reports are also used for estimates.
The market growth rate in the major economies such as the U.S., Japan, China etc.
are estimated individually.
The region wise distribution of the market consists of North America, Europe, Asia-Pacific,
and Rest of World with 18 countries, analyzed individually as follows:
NORTH AMERICA

USA, CANADA AND MEXICO

EUROPE

UNITED KINGDOM, GERMANY, FRANCE, SPAIN, ITALY, THE

NETHERLANDS, SWITZERLAND, RUSSIA AND REST OF EUROPE

ASIA-PACIFIC

CHINA, JAPAN, INDIA, SOUTH KOREA AND REST OF ASIA-PACIFIC

REST OF THE WORLD

BRAZIL, MIDDLE EAST, SOUTH AFRICA, REST OF LATIN AMERICA

AND REST OF AFRICA

KEY INDUSTRY ACTIVITIES

CESCA THERAPEUTICS ENTERS INTO COLLABORATIVE AGREEMENT WITH CENTER FOR
IMMUNE CELL THERAPIES AT MEMORIAL SLOAN KETTERING CANCER CENTER
AGILENT TECHNOLOGIES TO ACQUIRE SEAHORSE BIOSCIENCE, INDUSTRY LEADER IN
TOOLS FOR MEASURING CELL METABOLISM
INTERNATIONAL STEM CELL CORPORATION ANNOUNCES NEXT PHASE OF RESEARCH
COLLABORATION WITH ROHTO PHARMACEUTICAL CO., LTD. OF JAPAN
PARTNERS GET $12.3M TO ADVANCE GENOMIC MEDICINE
NEW STUDY DEMONSTRATES ABSENCE OF EXTRACTABLE ORGANIC CONTAMINANTS IN
MICRONICS POLYPROPYLENE SAMPLE STORAGE TUBES
VALEANT PHARMACEUTICALS TO ACQUIRE SYNERGETICS USA
SYSMEX RECEIVES IN-VITRO DIAGNOSTIC APPROVAL FOR MANUFACTURING AND
SALES OF THREE PLATELET AGGREGATION AGONIST REAGENT KITS
AMAG PHARMACEUTICALS COMPLETES ACQUISITION OF CORD BLOOD REGISTRY
BIOTEK SYNERGY NEO2 GRANTED CISBIO HTRF CERTIFICATION
AVITA MEDICAL ANNOUNCES NEW RESEARCH PARTNERSHIP WITH UNIVERSITY OF
HUDDERSFIELD
& many more.

For more information on this report publication, please reach us at:

sales@axisresearchmind.com